Publications in collaboration with researchers from University of Oxford (8)

2024

  1. Effects of cannabidiol on symptoms in people at clinical high risk for psychosis

    World Psychiatry

  2. Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol

    Psychological Medicine, Vol. 54, Núm. 5, pp. 993-1003

2023

  1. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk

    Schizophrenia Bulletin Open, Vol. 4, Núm. 1

2022

  1. Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists

    BMJ open, Vol. 12, Núm. 6, pp. e056355

2018

  1. Correction to: Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis (Neuropsychopharmacology, (2018), 43, 13, (2652-2659), 10.1038/s41386-017-0004-6)

    Neuropsychopharmacology

  2. Cortical GABA in subjects at ultra-high risk of psychosis: Relationship to negative prodromal symptoms

    International Journal of Neuropsychopharmacology, Vol. 21, Núm. 2, pp. 114-119

  3. Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: Replication in a second cohort

    Schizophrenia Bulletin, Vol. 44, Núm. 6, pp. 1323-1331

  4. Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

    Neuropsychopharmacology, Vol. 43, Núm. 13, pp. 2652-2659